A/Prof Mahesh Jayaram is a Clinician Scientist who works across research, higher education and clinical sectors. In his University role, he leads all graduate teaching programs across the Department of Psychiatry. He coordinates the Master of Psychiatry Course (MPsych), which is run both on-campus and online. Since 2015, he has been instrumental in co-designing, developing, marketing and coordinating the running of the online MPsych course along with colleagues within the University of Melbourne. This is now widely regarded as the most successful psychiatry training course in Australia. It is accredited as a Formal Education Course by the Royal Australia and New Zealand College of Psychiatrists (RANZCP). In addition, working closely with the World Psychiatric Association, he led the development ofGraduate Diploma of International Psychiatry program and developed the MOOC program– Foundations of International Psychiatry which has more than 8000 learners. He has developed innovative CPD modules for professionals. Clinically, he provides care for those with serious mental illness (SMI) and is a general psychiatrist interested in evidence based care. He sits on various teaching and training committees within the Northwestern Mental Health and on the Victorian Psychiatric Training Committee of RANZCP. His research interests span a number of areas including working as editor of Cochrane Schizophrenia Group since 2009 and recently appointmented as coordinating editor for Cochrane Schizophrenia. He is interstested in evaluating novel treatments for schizophrenia and has taught, authored and edited numerous Cochrane reviews relating to treatments of schizophrenia. His work comparing risperidone vs olanzapine was in the top most downloaded paper in 2006, as rated by Medscape. He has completed randomised controlled trials (one of them being a world’s first trial) evaluating the effectiveness of social media in disseminating evidence based information. He has been involved in work on guideline development for pharmacological treatment of acquired brain injuries. He obtained NMHRC funding to evaluate interventions to reduce mortality in those with SMI and part of NHMRC ideas grant to evaluate characteristics of muscarinic receptors in those with schizophrenia using PET scans. He is part of the PROCLAIM consortium evaluating clozapine induced myocarditits. He has obtained over $3.5 million in research funding and has authored over 40 peer reviewed publications and four book chapters, including a recent (2020) prestigious one in the Oxford Textbook of Psychiatry.